Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Нервные болезни
2020 / N 2

Головная боль и другие неврологические симптомы в структуре клинической картины новой коронавирусной инфекции (COVID-19)
Ю.Е. Нестеровский, Н.Н. Заваденко, А.А. Холин

References

1. Gusev EI, Martynov MYu, Boyko AN, Voznyuk IA, Lashch NYu, Sivertseva SA, Spirin NN, Shamalov NA. New coronavirus infection (COVID-19) and nervous system damage: mechanisms of neurological disorders, clinical manifestations, organization of neurological care. SS Korsakov Journal of Neurology and Psychiatry 2020;120(6):7-16 (In Russian).
2. Borges do Nascimento IJ, Cacic N, Abdulazeem HM, von Groote TC, Jayarajah U, Weerasekara I, Esfahani MA, Civile VT, Marusic A, Jeroncic A, Carvas N Jr, Pericic TP, Zakarija-Grkovic I, Guimarães SM, Bragazzi NL, Bjorklund M, Sofi-Mahmudi A, Altujjar M, Tian M, Arcani DMC, O’Mathúna DP, Marcolino MS. Novel coronavirus infection (COVID-19) in humans: a scoping review and meta-analysis. Journal of Clinical Medicine 2020 Mar;9(4):941.
3. Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, Li SB, Wang HY, Zhang S, Sheng JF, Gao HN, Cai HL, Qui JQ, Li LJ. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ 2020 Feb 27;368:m792.
4. Jin X, Lian JS, Hu JH, Gao J, Zheng L, Zhang YM, Hao SR, Jia HY, Cai H, Zhang XL, Yu GD, Xu KJ, Wang XY, Gu JQ, Zhang SY, Ye CY, Jin CL, Lu YF, Yu X, Yu XP, Huang JR, Xu KL, Ni Q, Yu CB, Zhu B, Li YT, Liu J, Zhao H, Zhang X, Yu L, Guo YZ, Su JW, Tao JJ, Lang GJ, Wu XX, Wu WR, Qv TT, Xiang DR, Yi P, Shi D, Chen Y, Ren Y, Qiu YQ, Li LJ, Sheng J, Yang Y. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut 2020 Jun;69(6):1002-9.
5. Tostmann A, Bradley J, Bousema T, Teun B, Yiek WK, Holwerda M, Bleeker-Rovers C, ten Oever J, Meijer C, Rahamat-Langendoen J, Hopman J, van der Geest-Blankert N, Wertheim H. Strong associations and moderate predictive value of early symptoms for SARS-CoV-2 test positivity among healthcare workers, the Netherlands, March 2020. Eurosurveillance 2020 Apr;25(16):2000508.
6. Headache Classification Committee of the International Headache Society (IHS). The International classification of headache disorders. 3rd ed. Cephalalgia 2018;38(1):1-211.
7. Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, Ueno M, Sakata H, Kondo K, Myose N, Nakao A, Takeda M, Haro H, Inoue O, Suzuki-Inoue K, Kubokawa K, Ogihara S, Sasaki T, Kinouchi H, Kojin H, Ito M, Onishi H, Shimizu T, Sasaki Y, Enomoto N, Ishihara H, Furuya S, Yamamoto T, Shimada S. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. International Journal of Infectious Diseases 2020 May;94:55-8.
8. Ye M, Ren Y, Lv T. Encephalitis as a clinical manifestation of COVID-19. Brain, Behavior, and Immunity 2020 Apr;S0889-1591(20)30465-7.
9. Bolay H, Gül A, Baykan B. COVID-19 is a real headache. Headache 2020 May 15;10.1111/head.13856. doi: 10.1111/head.13856. Online ahead of print.
10. Kabbani N, Olds JL. Does COVID-19 infect the brain? If so, smokers might be at a higher risk. Molecular Pharmacology 2020 May;97(5):351-3.
11. Cheng H, Wang Y, Wang GQ. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19. Journal of Medical Virology 2020 Jul;92(7):726-30.
12. Doobay MF, Talman LS, Obr TD, Tian X, Davisson RL, Lazartigues E. Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2007 Jan;292(1):R373-81.
13. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Miao X, Li Y, Hu B. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA. Neurology 2020 Apr;77(6):1-9.
14. Jackson L, Eldahshan W, Fagan SC, Ergul A. Within the brain: the renin angiotensin system. International Journal of Molecular Sciences 2018 Mar;19(3):876.
15. Bali A, Singh N, Jaggi AS. Renin-angiotensin system in pain: existing in a double life? Journal of the Renin-Angiotensin-Aldosterone System 2014 Dec;15(4):329-40.
16. Patil J, Schwab A, Nussberger J, Schaffner T, Saavedra JM, Imboden H. Intraneuronal angiotensinergic system in rat and human dorsal root ganglia. Regulatory Peptides 2010 Jun;162(1-3):90-8.
17. Imboden H, Patil J, Nussberger J, Nicoud F, Hess B, Ahmed N, Schaffner T, Wellner M, Müller D, Inagami T, Senbonmatsu T, Pavel J, Saavedrae JM. Endogenous angiotensinergic system in neurons of rat and human trigeminal ganglia. Regulatory Peptides 2009 Apr;154(1-3):23-31.
18. Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of migraine: a disorder of sensory processing. Physiological Reviews 2017 Apr;97(2):553-622.
19. Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Mocha H. Endothelial cell infection and endotheliitis in COVID-19. The Lancet 2020 May;395(10234):1417-8.
20. Li Y, Wang M, Zhou Y, Chang J. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. The Lancet 2020 Mar 03. Available from: https://ssrn.com/abstract=3550025 Accessed 2020 Jun 30.
21. Wang W, Sun Q, Bao Y, Liang M, Meng Q, Chen H, Li J, Wang X, Zhao S, Wang H, Xiao J, Chen L, Zheng J, Wang D, Jiao J, Han K. Analysis of risk factors for the thromboembolic events from 88 patients with COVID-19 pneumonia in Wuhan, China: a retrospective report. The Lancet 2020 Apr 06. Available from: https://ssrn.com/abstract=3559633 Accessed 2020 Jun 30.
22. Bibas M, Biava G, Antinori A. HIV-associated venous thromboembolism. Mediterranean Journal of Hematology and Infectious Diseases 2011;3(1):e2011030.
23. Squizzato A, Gerdes VE, Büller HR. Effects of human cytomegalovirus infection on the coagulation system. Thrombosis and Haemostasis 2005 Mar;93(3):403-10.
24. Uthman IW, Gharavi AE. Viral infections and antiphospholipid antibodies. Seminars in Arthritis and Rheumatism 2002 Feb;31(4):256-63.
25. Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, Clark C, Iba T. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. Journal of Thrombosis and Haemostasis 2020 May;18(5):1023-6.
26. Ciccia F, Rizzo A, Ferrante A, Guggino G, Croci S, Cavazza A, Salvarani C, Triolo G. New insights into the pathogenesis of giant cell arteritis. Autoimmunity Reviews 2017 Jul;16(7):675-83.
27. Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nature Medicine 2002 Feb;8(2):136-42.
28. Edvinsson L, Haanes KA, Warfvinge K. Does inflammation have a role in migraine? Nature Reviews. Neurology 2019 Aug;15(8):483-90.
29. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 2020 Feb;395(10223):497-506.
30. Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome; Board on the Health of Select Populations; Institute of Medicine. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: redefining an illness. Washington, DC: National Academies Press; 2015. The National Academies Collection: Reports funded by National Institutes of Health.
31. Bested AC, Marshall LM. Review of myalgic encephalomyelitis/chronic fatigue syndrome: an evidence-based approach to diagnosis and management by clinicians. Reviews on Environmental Health 2015;30(4):223-49.
32. Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain–Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? The Lancet 2020 May;19(5):383-4.
33. Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni G, Franciotta D, Baldanti F, Daturi R, Postorino P, Cavallini A, Micieli G. Guillain–Barré syndrome associated with SARS-CoV-2. The New English Journal of Medicine 2020 Jun;382(26):2574-6.
34. Gutiérrez-Ortiz C, Méndez A, Rodrigo-Rey S, San Pedro-Murillo E, Bermejo-Guerrero L, Gordo-Manas R, de Aragon-Gomez F, Benito-Leon J. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology 2020 Apr 17. doi: 10.1212/WNL.0000000000009619S. Online ahead of print.
35. Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). The New English Journal of Medicine 1956 Jul;255(2):57-65.
36. Rodríguez Uranga JJ, Delgado López F, Franco Macías E, Sánchez Arjona MB, Martínez Quesada C, Palomino García A. Síndrome de Miller-Fisher: hallazgos clínicos, infecciones asociadas y evolución en 8 pacientes [Miller-Fisher syndrome: clinical features, associated infections and clinical course in 8 cases]. Medicina Clinica (Barcelona) 2004 Feb;122(6):223-6.
37. Blanco-Marchite CI, Buznego-Suárez L, Fagúndez-Vargas MA, Méndez-Llatas M, Pozo-Martos P. Síndrome de Miller Fisher, oftalmoplejía interna y externa tras vacunación antigripal [Miller Fisher syndrome, internal and external ophthalmoplegia after flu vaccination]. Archivos de la Sociedad Española de Oftalmología 2008 Aug;83(7):433-5.
38. Mustafa NM, Selim LA. Characterisation of COVID-19 pandemic in paediatric age group: a systematic review and meta-analysis. Journal of Clinical Virology 2020 Jul;128:104395.
39. Cai J, Xu J, Lin D, Xu L, Qu Z, Zhang Y, Zhang H, Jia R, Liu P, Wang X, Ge Y, Xia A, Tian H, Chang H. Wang C, Li J, Wang J, Zeng M. A case series of children with 2019 novel coronavirus infection: clinical and epidemiological features. Clinical Infectious Diseases 2020 Feb 28;ciaa198. doi: 10.1093/cid/ciaa198. Online ahead of print.
40. Ji LN, Chao S, Wang YJ, Li XL, Mu XD, Lin MG, Jiang RM. Clinical features of pediatric patients with COVID-19: a report of two family cluster cases. World Journal of Pediatrics 2020 Jun;16(3):267-70.
41. CDC COVID-19 Response Team. Coronavirus disease 2019 in children – United States, February 12–April 2, 2020. Morbidity and Mortality Weekly Report 2020. Available from: https://doi.org/10.15585/mmwr.mm6914e4 Accessed 2020 Jun 30.
42. DeBiasi RL, Song S, Delaney M, Bell M, Smith K, Pershad J, Ansusunha E, Hahn A, Hamdy R, Haric N, Hanisch B, Jantausch B, Koay A, Steinhorn R, Newman K, Wessel D. Severe COVID-19 in children and young adults in the Washington, DC Metropolitan region. The Journal of Pediatrics 2020 May 13. doi: 10.1016/j.jpeds.2020.05.007. Online ahead of print.
43. She J, Liu L, Liu W. COVID-19 epidemic: disease characteristics in children. Journal of Medical Virology 2020 Jul;92(7):747-54.
44. Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. The Lancet 2020 May;395(10237):1607-8.
45. Castagnoli R, Votto M, Licari A, Brambilla I, Bruno R, Perlini S, Rovida F, Baldanti F, Marseglia GL. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review. JAMA Pediatrics 2020 Apr 22. doi: 10.1001/jamapediatrics.2020.1467. Online ahead of print.
46. Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, Bonanomi E, D’Antiga L. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. The Lancet 2020 Jun;395(10239):1771-8.
47. Kawasaki T. [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi 1967 Mar;16(3):178-222.
48. Kawasaki T. [Recognition of KD]. Nihon Rinsho 2008 Feb;66(2):225-8. Japanese. PMID: 18265454.
49. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974 Sep;54(3):271-6.
50. Alizargar J. The novel coronavirus (COVID-19) and the risk of Kawasaki disease in children. Journal of the Formosan Medical Association 2020 May 23. doi: 10.1016/j.jfma.2020.05.030. Online ahead of print.
51. Harahsheh AS, Dahdah N, Newburger JW, Portman MA, Piram M, Tulloh R, McCrindle BW, de Ferranti SD, Cimaz R, Truong DT, Burns JC. Missed or delayed diagnosis of Kawasaki disease during the 2019 novel coronavirus disease (COVID-19) pandemic. The Journal of Pediatrics 2020 Jul;222:261-2.
52. Rivera-Figueroa EI, Santos R, Simpson S, Garg P. Incomplete Kawasaki disease in a child with COVID-19. Indian Pediatrics 2020 May 09;S097475591600179. Online ahead of print.
53. Esper F, Shapiro ED, Weibel C, Ferguson D, Landry ML, Kahn JS. Association between a novel human coronavirus and Kawasaki disease. The Journal of Infectious Diseases 2005 Feb;191(4):499-502.
54. Moreira A. Kawasaki disease linked to COVID-19 in children. Nature Reviews Immunology 2020 May 27;1. doi: 10.1038/s41577-020-0350-1. Online ahead of print.
55. Tsai G, Coyle JT. N-acetylaspartate in neuropsychiatric disorders. Progress in Neurobiology 1995 Aug;46(5):531-40.
56. Baymeyeva NV, Miroshnichenko II. N-acetylaspartate is a biomarker of psychiatric and neurological disorders. SS Korsakov Journal of Neurology and Psychiatry 2015;115(8):54-8 (In Russian).
57. Bárány M, Spigos DG, Mok E, Venkatasubramanian PN, Wilbur AC, Langer BG. High resolution proton magnetic resonance spectroscopy of human brain and liver. Magnetic Resonance Imaging 1987;5(5):393-8.
58. Govindaraju V, Young K, Maudsley AA. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR in Biomedicine 2000 May;13(3):129-53.
59. Walker PM, Ben Salem D, Lalande A, Giroud M, Brunotte F. Time course of NAA T2 and ADC(w) in ischaemic stroke patients: 1H MRS imaging and diffusion-weighted MRI. Journal of the Neurological Sciences 2004 May;220(1-2):23-8.
60. Staffen W, Zauner H, Mair A, Kutzelnigg A, Kapeller P, Stangl H, Raffer E, Niederhofer H, Ladurner G. Magnetic resonance spectroscopy of memory and frontal brain region in early multiple sclerosis. The Journal of Neuropsychiatry and Clinical Neurosciences 2005 Summer;17(3):357-63.
61. Schuff N, Meyerhoff DJ, Mueller S, Chao L, Sacrey DT, Laxer K, Weiner MW. N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease. In: N-acetylaspartate: a unique neuronal molecule in the central nervous system. Moffett JR, Tieman SB, Weinberger DR, Coyle JT, Namboodiri MA, editors. New York, NY: Springer Science+Business Media; 2006: 241-62.
62. Vagnozzi R, Signoretti S, Cristofori L, Alessandrini F, Floris R, Isgro E, Ria A, Marziali S, Zoccatelli G, Tavazzi B, Del Bolgia F, Sorge R, Broglio SP, McIntosh TK, Lazzarino G. Assessment of metabolic brain damage and recovery following mild traumatic brain injury: a multicentre, proton magnetic resonance spectroscopic study in concussed patients. Brain 2010 Nov;133(11):3232-42.
63. Widerström-Noga E, Govind V, Adcock JP, Levin BE, Maudsley AA. Subacute pain after traumatic brain injury is associated with lower insular N-acetylaspartate concentrations. Journal of Neurotrauma 2016 Jul;33(14):1380-9.
64. Moffett JR, Arun P, Ariyannur PS, Namboodiri AMA. N-Acetylaspartate reductions in brain injury: impact on post-injury neuroenergetics, lipid synthesis, and protein acetylation. Frontiers in Neuroenergetics 2013 Dec;5:11.
65. Signoretti S, Marmarou A, Tavazzi B, Lazzarino G, Beaumont A, Vagnozzi R. N-Acetylaspartate reduction as a measure of injury severity and mitochondrial dysfunction following diffuse traumatic brain injury. Journal of Neurotrauma 2001 Oct;18(10):977-91.
66. Milovanova OA, Astanina SYu. Treatment of asthenoneurotic disorders in children. SS Korsakov Journal of Neurology and Psychiatry 2016;116(12):112-3 (In Russian).
67. Goryunova AV, Shevchenko YuS, Goryunov AV. Cogitum in pediatric neurology and psychiatry (practical application experience). SS Korsakov Journal of Neurology and Psychiatry 2019;119(7-2):58-66 (In Russian).
  

[ Содержание выпуска N 2 | Выпуски журнала | Список журналов ]